Catalyst Financial Partners LLC Vertex Pharmaceuticals Inc Transaction History
Catalyst Financial Partners LLC
- $511 Billion
- Q3 2024
A detailed history of Catalyst Financial Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Catalyst Financial Partners LLC holds 1,086 shares of VRTX stock, worth $431,435. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,086
Previous 1,085
0.09%
Holding current value
$431,435
Previous $509 Million
0.69%
% of portfolio
0.1%
Previous 0.11%
Shares
7 transactions
Others Institutions Holding VRTX
# of Institutions
1,724Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$10.7 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.2 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.47 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.69 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.58 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $102B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...